{"data":{"id":"us/21-cfr-314.152","jurisdiction":"us","citation":"21 CFR 314.152","heading":"Notice of withdrawal of approval of an application or abbreviated application for a new drug.","body":"If the Food and Drug Administration withdraws approval of an application or abbreviated application for a new drug, FDA will publish a notice in the Federal Register announcing the withdrawal of approval. If the application or abbreviated application was withdrawn for grounds described in § 314.150(a) or § 314.151, the notice will announce the removal of the drug from the list of approved drugs published under section 505(j)(6) of the act and shall satisfy the requirement of § 314.162(b).","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG","Subpart D—FDA Action on Applications and Abbreviated Applications"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"79b96ba782ae1f49f68de8cd1b09653e37f74575f2e21703b1b8914eb562fd99","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-314.151","next":"us/21-cfr-314.153"},"notice":"GroundRules: Original legal text. Not legal advice."}